(Q34565848)

3 August 2017

1 reference

title

Neuropsychiatric complications of antiretroviral therapy (English)

1 reference

3 August 2017

main subject

anti-retroviral agent

0 references

author name string

Michelle S Cespedes

series ordinal

1

1 reference

3 August 2017

Judith A Aberg

series ordinal

2

1 reference

3 August 2017

publication date

1 January 2006

1 reference

3 August 2017

1 reference

3 August 2017

volume

29

1 reference

3 August 2017

issue

10

1 reference

3 August 2017

page(s)

865-874

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200629100-00004

3 August 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629100-00004

Cerebrovascular changes in the basal ganglia with HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629100-00004

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629100-00004

Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629100-00004

Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629100-00004

HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629100-00004

Preliminary Data of a Prospective Study on Neuropsychiatric Side Effects After Initiation of Efavirenz

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629100-00004

Antiretroviral therapy-induced psychosis: case report and brief review of the literature

21 January 2018

1 reference

12 December 2020

Efavirenz-induced psychosis

1 reference

12 December 2020

Recurrence of post-traumatic stress disorder symptoms after initiation of antiretrovirals including efavirenz: a report of two cases

1 reference

12 December 2020

Central nervous system adverse effects with efavirenz: case report and review

1 reference

12 December 2020

Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398.

1 reference

12 December 2020

Efavirenz intoxication due to slow hepatic metabolism

1 reference

12 December 2020

Neuropsychiatric manifestations of HIV infection and AIDS

1 reference

12 December 2020

Tolerance of efavirenz-induced central nervous system side effects in HIV-infected individuals with a history of substance abuse

1 reference

12 December 2020

Manic syndrome associated with zidovudine treatment

1 reference

12 December 2020

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

1 reference

12 December 2020

Suppression of human immunodeficiency virus replication in human brain tissue by nucleoside reverse transcriptase inhibitors.

1 reference

12 December 2020

A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival

1 reference

12 December 2020

More on abacavir-induced neuropsychiatric reactions.

1 reference

12 December 2020

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

1 reference

12 December 2020

Meta-analysis of the relationship between HIV infection and risk for depressive disorders

1 reference

12 December 2020

Antiretroviral drugs and the central nervous system.

1 reference

12 December 2020

Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence

1 reference

12 December 2020

Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study

1 reference

12 December 2020

Neuropsychiatric reaction induced by clarithromycin

1 reference

12 December 2020

Neuropsychiatric reaction induced by clarithromycin in a patient on highly active antiretroviral therapy (HAART)

1 reference

12 December 2020

Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy

1 reference

12 December 2020

Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort

1 reference

12 December 2020

Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy

1 reference

12 December 2020

Drug points: Neuropsychiatric complications of nevirapine treatment

1 reference

12 December 2020

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Manic syndrome associated with zidovudine

1 reference

12 December 2020

Acute Meningoencephalitis in Chronic Human Immunodeficiency Virus (HIV) Infection: Putative Central Nervous System Escape of HIV Replication

1 reference

12 December 2020

Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Management of sudden psychiatric disorders related to efavirenz

1 reference

12 December 2020

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

1 reference

12 December 2020

Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia

1 reference

12 December 2020

Schizophrenic patients before and after HIV infection: a case-control study.

1 reference

12 December 2020

Manic syndrome associated with efavirenz overdose

1 reference

12 December 2020

Zidovudine toxicity. Clinical features and management

1 reference

12 December 2020

Neuropsychiatric reaction induced by abacavir

1 reference

12 December 2020

Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz

1 reference

12 December 2020

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma

1 reference

12 December 2020

Neurologic and psychiatric complications of antiretroviral agents

1 reference

12 December 2020

A manic episode associated with efavirenz therapy for HIV infection

1 reference

12 December 2020

10.2165/00002018-200629100-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1026558359

0 references

1 reference